BRAF and cancer: Previous studies demonstrating a constitutive fragmented mitochondrial morphology in oncogenic KRAS or BRAF driven cancers (34, 48, 50, 51) prompted us to seek whether such endogenously activating mutations in colorectal cancerous cell lines have any role in tumorigenesis.